Something went wrong with the connection!

Boisenews Now

Press Release

In The Queue: AcurX Pharmaceuticals Earnings…Here’s What Investors Need To Know Before Thursday ($ACXP)

Acurx Pharmaceuticals’ (NASDAQ: ACXP) earnings release is scheduled for Thursday, March 16, 2023. And like most biotechs, investors will be more focused on what the company says than what it

Read Full Article

Industrial Nitrogen Generator Market – Technology Type, Size, Design, End-use Industry, Top Manufacturers, and Regional Analysis 2021-2026| MarketsandMarkets™

Browse 209 market data Tables and 46 Figures spread through 222 Pages and in-depth TOC on “Industrial Nitrogen Generator Market” Industrial Nitrogen Generator Market by Technology Type (PSA, Membrane-based, Cryogenic

Read Full Article

Revolutionizing California’s Real Estate Industry – Just Better Cash Buyers Emerges as the Go-To Solutions Provider

Just Better Cash Buyers has been making waves in the real estate industry, offering innovative solutions to homeowners in California. As a company that specializes in buying homes for cash,

Read Full Article

Diabetic Foot Ulcers Emerging and Marketed Drugs Assessment (2023 Updates) | Clinical Trials, Latest FDA, EMA, and PMDA Approvals, Treatment Outlook, Competitive Landscape, and Key Companies

Delveinsight Business Research LLP As per DelveInsight’s assessment, about 30+ key pharma and biotech companies are working on 34+ pipeline drugs in the Diabetic Foot Ulcers therapeutics landscape based on

Read Full Article

T-Cell Lymphoma Emerging and Marketed Drugs Assessment (2023 Updates) | Clinical Trials, Latest FDA, EMA, and PMDA Approvals, Treatment Outlook, Competitive Landscape, and Key Companies

Delveinsight Business Research LLP As per DelveInsight’s assessment, about 85+ key pharma and biotech companies are working on 85+ pipeline

Read Full Article

Graft-Versus-Host Disease (GVHD) Emerging and Marketed Drugs Assessment (2023 Updates) | Clinical Trials, Latest FDA, EMA, and PMDA Approvals, Treatment Outlook, Competitive Landscape, Key Companies

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 60+ key pharma and biotech companies are working on 60+

Read Full Article

Malignant Pleural Mesothelioma Emerging and Marketed Drugs Assessment (2023 Updates) | Clinical Trials, Latest FDA, EMA, and PMDA Approvals, Treatment Outlook, Competitive Landscape, and Key Companies

Delveinsight Business Research LLP As per DelveInsight’s assessment, about 20+ key pharma and biotech companies are working on 20+ pipeline

Read Full Article

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Emerging and Marketed Drugs Assessment (2023 Updates)| Clinical Trials, Latest FDA, EMA, and PMDA Approvals, Key Players, Competitive Landscape

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 10+ key pharma and biotech companies are working on 12+

Read Full Article

Cutaneous T-Cell Lymphoma (CTCL) Emerging and Marketed Drugs Assessment (2023 Updates) | Clinical Trials, Latest FDA, EMA, and PMDA Approvals, Treatment Outlook, Competitive Landscape, Key Companies

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 25+ key pharma and biotech companies are working on 27+

Read Full Article

Pyruvate Kinase Deficiency (PKD) Market to Register Stunning Growth During the Forecast Period (2022-2032) – DelveInsight | Key Companies – Agios Pharmaceuticals, Rocket Pharmaceuticals

Delveinsight Business Research LLP As per DelveInsight, the Pyruvate Kinase Deficiency therapeutics market is anticipated to evolve immensely in the

Read Full Article

Categories